Current application status and prospect of hybrid coronary revascularization
- VernacularTitle:杂交冠状动脉血运重建技术应用现状及展望
- Author:
Tong DING
1
;
Liuzhong SHEN
1
;
Shengshou HU
1
Author Information
1. Department of Cardiovascular Surgery, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, P.R.China
- Publication Type:Journal Article
- Keywords:
Hybrid coronary revascularization;
coronary artery bypass grafting;
percutaneous coronary intervention
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2021;28(07):863-869
- CountryChina
- Language:Chinese
-
Abstract:
Hybrid coronary revascularization (HCR) combining with coronary artery bypass grafting (CABG) has a long-term patency of left internal mammary artery to left anterior descending artery (LIMA-LAD) grafting, and the percutaneous coronary intervention (PCI) has a minimal invasiveness. It provides an alternative revascularization for patients with coronary heart disease. For patients who meet the HCR indications, most studies suggest that HCR can significantly reduce perioperative trauma, and offer favorable mid- and long-term prognosis, which is comparable with traditional revascularization strategies. Based on the major research results in this field in the past 10 years, we review the current application status and discuss the potential future direction of HCR in this paper.
